Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells
✍ Scribed by Hung-Yun Lin; MingZeng Sun; Heng-Yuan Tang; Tessa M. Simone; Yun-Hsuan Wu; Jennifer R. Grandis; H. James Cao; Paul J. Davis; Faith B. Davis
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 545 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cyclooxygenase‐2 (COX‐2) content is increased in many types of tumor cells. We have investigated the mechanism by which resveratrol, a stilbene that is pro‐apoptotic in many tumor cell lines, causes apoptosis in human head and neck squamous cell carcinoma UMSCC‐22B cells by a mechanism involving cellular COX‐2. UMSCC‐22B cells treated with resveratrol for 24 h, with or without selected inhibitors, were examined: (1) for the presence of nuclear activated ERK1/2, p53 and COX‐2, (2) for evidence of apoptosis, and (3) by chromatin immunoprecipitation to demonstrate p53 binding to the p21 promoter. Stilbene‐induced apoptosis was concentration‐dependent, and associated with ERK1/2 activation, serine‐15 p53 phosphorylation and nuclear accumulation of these proteins. These effects were blocked by inhibition of either ERK1/2 or p53 activation. Resveratrol also caused p53 binding to the p21 promoter and increased abundance of COX‐2 protein in UMSCC‐22B cell nuclei. Resveratrol‐induced nuclear COX‐2 accumulation was dependent upon ERK1/2 activation, but not p53 activation. Activation of p53 and p53‐dependent apoptosis were blocked by the COX‐2 inhibitor, NS398, and by transfection of cells with COX‐2‐siRNA. In UMSCC‐22B cells, resveratrol‐induced apoptosis and induction of nuclear COX‐2 accumulation share dependence on the ERK1/2 signal transduction pathway. Resveratrol‐inducible nuclear accumulation of COX‐2 is essential for p53 activation and p53‐dependent apoptosis in these cancer cells. J. Cell. Biochem. 104: 2131–2142, 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Nonfunctional p53 and especially upregulation of Bcl-x(L) result in advanced disease and poor prognosis of patients suffering head and neck squamous cell carcinoma (HNSCC). Aberrancies of Bcl-x(L) and/or p53 in HNSCC lead to inability of anticancer drugs to induce apoptosis. Bcl-x(L) and/or mutated
We have examined the ability of gamma-irradiation and bleomycin to induce apoptosis in a model system consisting of cell lines derived from naturally occurring human head-and-neck squamous-cell carcinomas with contrasting p53 status and expression levels of pro- and anti-apoptotic molecules. Followi
## Background: A critical factor for successful organ preservation treatment in head and neck cancer may be selecting tumors that respond to chemotherapy and radiation. previous results in patients indicated that tumors that overexpressed p53 were more sensitive to chemotherapy than those that did
## Abstract ## Background. The p53 protein, a well‐known tumor suppressor that functions primarily as a transcription factor, initiates cell cycle arrest and apoptosis after genotoxic stress. The antiapoptotic regulator Bcl‐2 is a downstream modulator of p53‐induced apoptosis. Loss of function of
## Abstract ## Background. Although cyclooxygenase‐2 (COX‐2) has been suggested to play an important role in carcinogenesis, the effects of tumor suppressors on COX‐2 gene expression and the combined antitumor effects of tumor suppressors and COX‐2 inhibitors have rarely been investigated. ## Met